EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next?

Michael X Fu iD, Peter Simmonds, Monique Andersson, Heli Harvala iD

Reviews in Medical Virology · 2024

DOI: 10.1002/rmv.2525 ↗

At a glance

Übersichtsarbeit in Reviews in Medical Virology, 2024. Written by Michael X Fu and 3 co-authors. Institution: Nuffield Department of Medicine, University of Oxford, Oxford, UK. Major MEDLINE topics: Hepatitis B, Hepatitis B, Chronic. Cited 22 times so far (Crossref); 112 references. The full text is freely available (open access, CC BY 4.0). Funded by: The National Institute for Health and Care Research.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Blood transfusion is a vital procedure, where transfusion‐transmitted infection of hepatitis B virus (HBV) remains an important issue, especially from blood donors with occult hepatitis B virus infection (OBI). Occult hepatitis B virus infection is a complex entity to detect using surrogate blood biomarkers for intrahepatic viral transcriptional activity, requiring a continually refined battery of tests utilised for screening. This review aims to critically evaluate the latest advances in the current blood biomarkers to guide the identification of OBI donors and discuss novel HBV markers that could be introduced in future diagnostic practice. Challenges in detecting low HBV surface antigen levels, mutants, and complexes necessitate ultrasensitive multivalent dissociation assays, whilst HBV DNA testing requires improved sensitivity but worsens inaccessibility. Anti‐core antibody assays defer almost all potentially infectious donations but have low specificity, and titres of anti‐surface antibodies that prevent infectivity are poorly defined with suboptimal sensitivity. The challenges associated with these traditional blood HBV markers create an urgent need for alternative biomarkers that would help us better understand the OBI. Emerging viral biomarkers, such as pre‐genomic RNA and HBV core‐related antigen, immunological HBV biomarkers of T‐cell reactivity and cytokine levels, and host biomarkers of microRNA and human leucocyte antigen molecules, present potential advances to gauge intrahepatic activity more accurately. Further studies on these markers may uncover an optimal diagnostic algorithm for OBI using quantification of various novel and traditional blood HBV markers. Addressing critical knowledge gaps identified in this review would decrease the residual risk of transfusion‐transmitted HBV infection without compromising the sustainability of blood supplies.

Subjects

MeSH terms (MEDLINE)

Hepatitis BHepatitis B, ChronicHumansHepatitis B virusHepatitis B AntibodiesBlood TransfusionHepatitis B Core AntigensBlood DonorsBiomarkersDNA, Viral

Author keywords

HBVblood safetydiagnosticserum markers

Substances

Hepatitis B AntibodiesHepatitis B Core AntigensBiomarkersDNA, Viral

Authors and institutions

  • Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Department of Infection, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Microbiology Services, NHS Blood and Transplant, Colindale, UK.
  • Infection and Immunity, University College London, London, UK.

ORCID profiles: Michael X Fu, Heli Harvala

Funding

  • The National Institute for Health and Care Research

Cite

APA

Fu, M. X., Simmonds, P., Andersson, M., & Harvala, H. (2024). Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next?. Reviews in Medical Virology. https://doi.org/10.1002/rmv.2525

Vancouver

Fu MX, Simmonds P, Andersson M, Harvala H. Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next?. Reviews in Medical Virology. 2024. doi:10.1002/rmv.2525

BibTeX
@article{Fu2024,
  author = {Fu, Michael X and Simmonds, Peter and Andersson, Monique and Harvala, Heli},
  title = {Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next?},
  journal = {Reviews in Medical Virology},
  year = {2024},
  doi = {10.1002/rmv.2525}
}
Start for free →